C1QTNF3 and coronary artery disorder: CTRP3 serum levels in patients with CAD (group II and IV) were significantly lower than the control group (both p < .05) and after adjusting for sex, age, BMI, medication and adiponectin serum levels, only the difference between control and CAD groups remained significant (p = 0.016).